Publications by authors named "Isaac A Goldberg"

Tissue availability remains an important limitation of single-cell genomic technologies for investigating cellular heterogeneity in human health and disease. BAL represents a minimally invasive approach to assessing an individual's lung cellular environment for diagnosis and research. However, the lack of high-quality, healthy lung reference data is a major obstacle to using single-cell approaches to study a plethora of lung diseases.

View Article and Find Full Text PDF

Objective: Systemic sclerosis (SSc) is characterized by immune activation, vasculopathy, and unresolving fibrosis in the skin, lungs, and other organs. We performed RNA-sequencing analysis on skin biopsy samples and peripheral blood mononuclear cells (PBMCs) from SSc patients and unaffected controls to better understand the pathogenesis of SSc.

Methods: We analyzed these data 1) to test for case/control differences and 2) to identify genes whose expression levels correlate with SSc severity as measured by local skin score, modified Rodnan skin thickness score (MRSS), forced vital capacity (FVC), or diffusing capacity for carbon monoxide (DLco).

View Article and Find Full Text PDF
Article Synopsis
  • Some patients with COVID-19 develop severe pneumonia and acute respiratory distress syndrome (ARDS), prompting studies on their unique immune responses.
  • Researchers analyzed lung fluid samples from COVID-19 patients and other pneumonia cases to investigate immune cell activity.
  • Findings revealed that SARS-CoV-2 infects alveolar macrophages, leading to a cyclical interaction with T cells that enhances inflammation in the lungs.
View Article and Find Full Text PDF

Some patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) develop severe pneumonia and acute respiratory distress syndrome (ARDS). Distinct clinical features in these patients have led to speculation that the immune response to virus in the SARS-CoV-2-infected alveolus differs from that in other types of pneumonia. Here we investigate SARS-CoV-2 pathobiology by characterizing the immune response in the alveoli of patients infected with the virus.

View Article and Find Full Text PDF